SCHEMBL1652964

SCHEMBL1652964

CC(=O)OC(CC(=O)O)C(=O)OC(=O)C(CC(=O)O)OC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 3/20 0.37
TDP1 Q9NUW8 2/20 0.35
MMP12 P39900 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
HRH1 P35367 1/20 0.32
KMT2A Q03164 1/20 0.32
GALR3 O60755 1/20 0.32
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6157372 1.00 ALOX15 (0.47) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL9394852 0.91 ALOX15 (0.41) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL29210738 0.85 ALOX15 (0.46) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL1656739 0.85 ALOX15 (0.46) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL9664881 0.83 ALDH1A1 (0.44) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL29000852 0.82 ALOX15 (0.50) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL5310540 0.82 ALOX15 (0.50) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL581924 0.82 ALOX15 (0.50) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL18206215 0.80 ALOX15 (0.42) ALOX15SMN1; SMN2LMNATSHRTDP1
SCHEMBL18221179 0.80 ALOX15 (0.42) ALOX15SMN1; SMN2LMNATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117222615-A Process for the preparation of phenyl ketones 阿尔萨达股份公司 2023-12-12 CN claimed
EP-2305402-B1 METHOD FOR PRODUCING SILVER-CONTAINING POWDER AND CONDUCTIVE PASTE USING THE SAME DAINIPPON INK & CHEMICALS (JP) 2017-11-29 EP claimed
US-10696852-B2 Silver paste, and conductive molded article obtained using same DIC CORPORATION (JP) 2020-06-30 US disclosed
US-20170342279-A1 SILVER PASTE, AND CONDUCTIVE MOLDED ARTICLE OBTAINED USING SAME DIC CORPORATION (JP) 2017-11-30 US disclosed
EP-2305402-B1 METHOD FOR PRODUCING SILVER-CONTAINING POWDER AND CONDUCTIVE PASTE USING THE SAME DAINIPPON INK & CHEMICALS (JP) 2017-11-29 EP disclosed
EP-3232445-A1 SILVER PASTE, AND CONDUCTIVE MOLDED ARTICLE OBTAINED USING SAME DIC Corporation (JP) 2017-10-18 EP disclosed
US-20110180764-A1 SILVER-CONTAINING POWDER, METHOD FOR PRODUCING THE SAME, CONDUCTIVE PASTE USING THE SAME, AND PLASTIC SUBSTRATE DIC CORPORATION (JP) 2011-07-28 US disclosed
EP-2305402-A1 SILVER-CONTAINING POWDER, METHOD FOR PRODUCING THE SAME, CONDUCTIVE PASTE USING THE SAME, AND PLASTIC SUBSTRATE DIC Corporation (JP) 2011-04-06 EP disclosed
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed
JP-2001226368-A METHOD FOR PRODUCING O-ACETYLMALIC ANHYDRIDE MITSUI CHEMICALS INC 2001-08-21 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 ALOX15 225/4885SMN1; SMN2 3819/4885LMNA 4373/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 ALOX15 214/4885SMN1; SMN2 3509/4885LMNA 4464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.